Gil | BioAsset Advisors

Home
Who We Are
What We Do
Success Stories
Contact Us

Success Stories

Assessment of the Market Opportunity and Optimal Development Path for a Novel Drug in Women’s Health
Assessment of the Market Potential for a Novel Hypercholesterolemia Drug
Determination of the Optimal Strategy for a non-US Drug to Enter the US Market

BioAssets Advisors has the experience and skills to turn your science into increased shareholder value.
To learn more call us at 919.883.2063 or email info@BioAssetAdvisors.com.